Breaking News

BIA Separations, Nuvonis Partner for Gene Therapy

To simplify the technical challenges associated with managing the upstream/downstream process interface

BIA Separations, a leading biochromatography development and manufacturing company, and Nuvonis Technologies, a biotech company providing innovative production cell banks, have signed a partnership agreement. The companies will offer solutions to meet the growing demand for vaccine and gene therapy production, and tackle the technical challenges associated with managing the upstream/downstream process interface.   The partnership agreement will provide customers with an offering that com...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters